Author:
Hyyti Outi M.,Portman Michael A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference64 articles.
1. Akiyama TE, Lambert G, Nicol CJ, Matsusue K, Peters JM, Brewer HB, Jr., et al. Peroxisome proliferator-activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western diet. J Biol Chem 2004;279:20874–81.
2. Araki O, Ying H, Furuya F, Zhu X, Cheng SY. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action. Proc Natl Acad Sci U S A 2005;102:16251–6.
3. Bogazzi F, Hudson LD, Nikodem VM. A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor. J Biol Chem 1994;269:11683–6.
4. Buroker NE, Young ME, Wei C, Serikawa K, Ge M, Ning XH, et al. The dominant negative thyroid hormone receptor {beta} mutant {Delta}337T alters peroxisome proliferator-activated receptor {alpha} signaling in heart. Am J Physiol Endocrinol Metab 2006.
5. Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P, et al. Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol Endocrinol 1997;11:1278–90.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献